Nociceptin stimulates locomotion and exploratory behaviour in mice

European Journal of Pharmacology

Volumn 317, Issue 1, 1996, Pages 9-13

  Florin, Sébastien ^a   Suaudeau, Charles ^a   Meunier, Jean Claude ^b   Costentin, Jean ^a  

^a Faculte de Medecine et Pharm de R   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Dopamine transmission; Exploratory behavior; Locomotor activity; Nociceptin

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NALOXONE; NOCICEPTIN; OPIATE AGONIST; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; EXPLORATORY BEHAVIOR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; HALOPERIDOL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; RECEPTORS, OPIOID; STIMULATION, CHEMICAL;

EID: 0030581735     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00707-8     Document Type: Article

References (18)

1. Aceto, M.D., M.C. Kean and D.B. Pearl, 1969, Effects of opiates and opiate antagonists on the Straub tail reaction in mice, Br. J. Pharmacol. 36, 2, 225.
2. Blumberg, H., H.B. Dayton and P.S. Wolf, 1966, Counteraction of narcotic antagonist analgesics by the narcotic antagonist naloxone, Proc. Soc. Exp. Biol. 123, 755.
3. Bousselmame, R., M. Eustache, A. Michael-Titus and J. Costentin, 1991, Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats, Neuropharmacology 8, 865.
4. Boissier, J.R. and P. Simon, 1962, La réaction d'exploration chez la Souris, Thérapie 17, 1225.
5. Chaillet, P., H. Marçais-Collado and J. Costentin, 1983, Catatonic or hypotonic immobility induced in mice by intracerebroventricular injection on mice of kappa opioid receptor agonists as well as enkephalins or inhibitors of their degradation, Life Sci. 33, 21, 210.
6. Costentin, J., 1996, Diversité des médicaments éveillants. Unicité mécanistique?, in: Sciences et Défense 96: Nouvelles Avancées Scientifiques et Techniques, ed. Ministère de la Défense (Cédocar) p. 153.
7. Cox, B., C. Ennis and G. Foote, 1980, Relative potency of some neuroleptics as antagonists at dopamine receptors in vivo compared with their reported ability to displace haloperidol binding in vitro, Br. J. Pharmacol. 681, 172.
8. Haley, J.J. and N.G. Mc Cormick, 1957, Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse, Br. J. Pharmacol. 12, 12.
9. Iorio, L.C., A. Barnett, F.H. Leitz, V.P. Houser and C.A. Korduba, 1983, SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems, J. Pharmacol. Exp. Ther. 226, 462.
10. Marçais-Collado, H., P. Chaillet and J. Costentin, 1983, Inhibition of spontaneous climbing behavior elicited in mice by opiates, J. Pharmacol. Exp. Ther. 227, 2, 466.
11. 1 receptor, Nature 377, 532.
12. Michael-Titus, A., N. Dourmap, H. Caline, J. Costentin and J.-C. Schwartz, 1988, Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J), Neuropharmacology 28, 117.
13. Michael-Titus, A., N. Dourmap and J. Costentin, 1989, Mu and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice, Neuropeptides 13, 235.
14. Michael-Titus, A., N. Dourmap, J. Costentin and J.-C. Schwartz, 1990, Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice, Neuropeptides 15, 89.
15. Mollereau, C., M. Parmentier, P. Mailleux, J.-L. Butour, C. Moisand, P. Chalon, D. Caput, G. Vassart and J.-C. Meunier, 1994, ORL1 a novel member of the opioid receptor family. Cloning, functional expression and localization, FEBS Lett. 341, 33.
16. Pulvirenti, L. and G.F. Koob, 1994, Dopamine receptor agonists, partial agonists and psychostimulant addiction, Trends Pharmacol. Sci. 15, 374.
17. Reinscheid, R.K., H.-P. Nothacker, A. Bourson, A. Ardati, R.A. Henningsen, J.R. Bunzow, D.-K. Grandy, H. Langen, F.J. Monsma Jr. and O. Civelli, 1995, Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor, Science 270, 792.
18. Sawynock, T., C. Pinsky and F. La Bella, 1979, Minireview on the specificity of naloxone as an opiate antagonist, Lite Sci. 25, 1621.